Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  KHRNF | KHRWF | V.KHRN.WT.H

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Bullboard Posts
Comment by PBOUN88on Sep 04, 2018 1:50pm
189 Views
Post# 28560050

RE:Khrn Price Rise

RE:Khrn Price RiseMany things are affecting the share price. If you think about it, the management team is super experienced and influencial, plus they will be starting their sales soon as per CEO, plus their cost per gram I think will be the lowest in the industry plus the industry in general is moving forward with aquisitions and partnerships etc... plus their plans for an international expansion in Mexico and south America plus having the former president of Mexico on their BOD is not a usual thing... so we will see... Plus don't forget they have around 50M outstanding shares in total so it's a combination of a lot of factors. This company has a promising future but it will all depend on timing, on commercial activities and future partnerships. Look at it as a long term investment not a quick way to make money. I would compare them to Canopy in 2014 (previously Bedrocan). Good luck :) Cheers.
Bullboard Posts